These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1516366)

  • 1. Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women.
    Landgren BM; Hall PE; Cekan SZ
    Contraception; 1992 Apr; 45(4):343-9. PubMed ID: 1516366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone-releasing vaginal rings for use in postpartum contraception. I. In vitro release rates of progesterone from core-loaded rings.
    Matlin SA; Belenguer A; Hall PE
    Contraception; 1992 Apr; 45(4):329-41. PubMed ID: 1516365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year.
    Landgren BM; Jonsson B; Cekan SZ
    Contraception; 1995 Apr; 51(4):255-60. PubMed ID: 7796592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
    Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
    Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of a contraceptive vaginal ring releasing 3-keto-desogestrel.
    Jackson R; Newton JR
    Contraception; 1989 Jun; 39(6):653-64. PubMed ID: 2752753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal progesterone for contraception.
    Victor A; Jackanicz TM; Johansson ED
    Fertil Steril; 1978 Dec; 30(6):631-5. PubMed ID: 729823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
    Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
    Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between sex hormone binding globulin and levonorgestrel released from vaginal rings in women.
    Cekan SZ; Jia M; Landgren BM; Diczfalusy E
    Contraception; 1985 Apr; 31(4):431-9. PubMed ID: 3924477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
    Davies GC; Feng LX; Newton JR; Dieben TO; Coelingh-Bennink HJ
    Contraception; 1992 May; 45(5):511-8. PubMed ID: 1623721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New hormonal methods of contraception.
    Newton JR
    Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):87-101. PubMed ID: 8736724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of research and development of vaginal contraceptive rings as a fertility control method in the female.
    Roy S; Mishell Dr
    Res Front Fertil Regul; 1983 May; 2(4):1-10. PubMed ID: 12227323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
    Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S
    Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol.
    Olsson SE; Odlind V
    Contraception; 1990 Nov; 42(5):563-72. PubMed ID: 2272184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal rings for contraception: endocrine parameters.
    Olsson SE
    Adv Contracept Deliv Syst; 1992; 8(1-2):71-3. PubMed ID: 12285565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo release characteristics of a multi-compartment vaginal ring releasing 3-keto-desogestrel.
    Jackson R; Newton JR
    Contraception; 1989 Nov; 40(5):615-21. PubMed ID: 2612167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of contraceptive vaginal rings].
    Elstein M; Jackson R; Hickling D; Assendorp R
    Contracept Fertil Sex (Paris); 1992 Jan; 20(1):15-9. PubMed ID: 12343624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaginal contraception with steroids].
    Levrier M
    Contracept Fertil Sex (Paris); 1993 Nov; 21(11):837-8. PubMed ID: 12287400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.